SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Charles River Laboratories sets Nov. 4 Q3 2026 earnings call

Charles River Laboratories will report third-quarter 2026 results on Nov. 4 before market open and hold a conference call that morning at 9:00 a.m. ET.

--()--October 09, 2026- Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2026 financial results on Wednesday, November 4(th), before the market opens. m. ET.

com. A replay will be accessible through the same website. About Charles River Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

com (END) Dow Jones Newswires October 09, 2026 08:01 ET (12:01 GMT) The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.